Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD.
暂无分享,去创建一个
Emiel F M Wouters | E. Wouters | A. Schols | Karin H Groenewegen | Annemie M W J Schols | K. Groenewegen
[1] R. Hubbard,et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease , 2001, Thorax.
[2] E. Wouters,et al. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. , 2001, The European respiratory journal.
[3] D. Niewoehner,et al. Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial. , 2000, American journal of respiratory and critical care medicine.
[4] M. Greenstone,et al. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer , 2000, Thorax.
[5] S. Hurd,et al. The impact of COPD on lung health worldwide: epidemiology and incidence. , 2000, Chest.
[6] D. Postma,et al. Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. , 1999, American journal of respiratory and critical care medicine.
[7] J. Vestbo,et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[8] J C Jager,et al. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. , 1999, Respiratory medicine.
[9] D. Brooks,et al. Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society. , 1999, Chest.
[10] D. Niewoehner,et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.
[11] A. Dirksen,et al. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[12] F. Maltais,et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[13] E. Wouters,et al. Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease , 1998 .
[14] K. Ström. Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: a risk factor for hospitalization and mortality in women. , 1998, Respiratory medicine.
[15] F. Forastiere,et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. , 1997, The European respiratory journal.
[16] C. Mcevoy,et al. Adverse effects of corticosteroid therapy for COPD. A critical review. , 1997, Chest.
[17] D. Postma,et al. Risk factors for accelerated decline among patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[18] L Goldman,et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.
[19] M. Decramer,et al. Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.
[20] P. Macklem,et al. Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[21] W. Knaus,et al. Hospital and 1-Year Survival of Patients Admitted to Intensive Care Units With Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 1995 .
[22] R. Pistelli,et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. , 1995, The American journal of medicine.
[23] M. Decramer,et al. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.
[24] K. Ström. Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy. , 1993, The American review of respiratory disease.
[25] M. Decramer,et al. Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma. , 1992, The American review of respiratory disease.
[26] R. Dittus,et al. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. , 1991, Annals of internal medicine.
[27] W. Gibbons,et al. Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure. , 1989, Chest.
[28] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[29] N. Anthonisen,et al. Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.
[30] B. Burrows,et al. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. , 1979, The American review of respiratory disease.
[31] B. Burrows,et al. Prediction of survival in patients with chronic airway obstruction. , 1969, The American review of respiratory disease.
[32] M. H. Williams,et al. Prognosis of patients with chronic obstructive pulmonary disease after hospitalization for acute ventilatory failure: a three-year follow-up study. , 1966, The American review of respiratory disease.